Enter one or more items to select relevant trials (e.g. indications…)

Age span:

Study state:

Number of records: 19
Title of the trial Diagnosis
Efficacy and safety of Fixed-Dose Combination (FDC) products containing trazodone and gabapentin in patients affected by painful diabetic neuropathy: randomized, controlled, dose finding study. diabetic neuropathy
A Phase 2, 4 Week Randomized, Double-Blind, Parallel Group, Placebo Controlled Proof of Concept Study to Evaluate Efficacy, Safety and Tolerability of GRC 17536 in Patients with Painful Diabetic Peripheral Neuropathy Diabetic Peripheral Neuropathy
A randomised three week double-blind crossover study to compare the efficacy and safety of CNV2197944 75 mg tid versus placebo in the treatment of neuropathic pain in patients with diabetic peripheral neuropathy diabetic peripheral neuropathy
A multicenter, randomized, double-blind, placebo and active controlled study comparing the analgesic efficacy and safety of ABT-639 to placebo in subjects with diabetic neuropathic pain diabetic neuropathic pain
A randomised, controlled, Long-term Safety study Evaluating the Effect of Repeated Applications of Qutenza plus Standard of care versus standard of care alone in subjects with Painful Diabetic Peripheral Neuropathy in subjects with painful diabetic peripheral neuropathy
A phase 3B multicenter, double-blind, randomized, placebo-controlled cross-over efficacy and safety study of pregabalin in the treatment of patients with painful diabetic peripheral neuropathy and pain on walking (protocol A0081269) painful diabetic peripheral neuropathy
A study of Pregabalin in the treatment of subjects with painful diabetic peripheral neuropathy with background treatment of NSAID for other pain conditions painful diabetic peripheral neuropathy with background treatment of NSAID for other pain conditions
Prospective, randomised, multi-centre, blind-observer, controlled, parallel-group study comparing the efficacy and the safety of DERMAGEN versus conventionnal treatment in the treatment of diabetic neuropthic foot ulcer diabetic neuropathic foot ulcer
A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Parallel Group Study of the Safety, Tolerability and Efficacy of V3381 for Up to 13 Weeks in Patients with Diabetic Peripheral Neuropathic Pain (DPNP) Diabetic Peripheral Neuropathic Pain (DPNP)
An exploratory, randomised, double-blind, single-dummy, placebo controlled, parallel group study to demonstrate the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) in addition to pregabalin compared to pregabalin alone in opioid-naive subjects treated with pregabalin suffering from moderate to severe pain due to diabetic polyneuropathy pain due to diabetic polyneuropathy
A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy painful peripheral diabetic polyneuropathy
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894 versus Placebo in Subjects with Diabetic Neuropathic Pain. Diabetic Neuropathic Pain
A double-blind, placebo-controlled, randomised, parallel-group study evaluating the efficacy and tolerability of oral BVT.115959, a novel A2A agonist, versus placebo in the treatment of diabetic neuropathic pain. Diabetic neuropathic pain
Efficacy and safety of eslicarbazepine acetate (BIA 2-093) as therapy for patients with painful diabetic neuropathy: a double-blind, double-dummy, randomised, placebo-controlled, parallel-group, multi-centre clinical trial Diabetic neuropathy
A randomised, double-blind, placebo-controlled trial of [S,S]-reboxetin in patients with chronic painful diabetic peripheral neuropathy Diabetic peripheral neuropathy
Proof-of-concept study of the analgesic effects of 12 weeks of repeated doses of F13640 in patients with moderately to severely painful peripheral diabetic polyneuropathy: a multi-center, randomised, double-blind, placebo-controlled, parallel-group study Diabetic polyneuropathy
A multi-center, randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of 400 mg/day Lacosamide in subjects with painful distal diabetic neuropathy using two different titration schemes diabetic neuropathy
Safety and efficacy of lidocaine, 5% medicated plaster in comparison with pregabalin in postherpetic neuralgia and diabetic polyneuropathic pain diabetic polyneuropathic pain
A double-blind, randomised, placebo-controlled, parallel-group study of Sativex in the treatment of subjects with pain due to diabetic neuropathy pain due to diabetic neuropathy
Pursuant to Section 99 par. 1 indent f) (2) of Act No. 378/2007 Coll., on Pharmaceuticals and on Amendments to Some Related Acts (Act on Pharmaceuticals) as amended, the State Institute for Drug Control publishes information about clinical trials approved in the Czech Republic.
Database included clinical trials approved since the effect of the Act on Pharmaceuticals. Information about clinical trials from the year 2004 – 2007 are being supplemented continuously.
Database, according to Act, doesn´t include bioequivalence trials and clinical trials in phase I (i.e. first-in-man trials, the first stage of testing in human subjects).

Glossary of clinical trials terms:
Sponsor = An individual, company, institution or organization which takes responsibility for the initiation, management and/or financing of a clinical trial.
Study code / Protocol number = trial identifying number for sponsor
EudraCT number = EU trial identifying number
Subject = an individual who participates in a clinical trial, either as a recipient of the investigational product(s) or as a control; patient or healthy volunteer.
MEK = Ethics Committee for Multicentric Clinical Trials
Double-blind study = A clinical trial design in which neither the participating individuals (subjects) nor the study staff knows which participants are receiving the investigational drug and which are receiving a placebo or another therapy.
Randomized trial = A study in which participants/subjects are randomly (i.e. by chance) assigned to one of two or more treatment arms of a clinical trial.
Multicentric trial = a clinical trial conducted according to a single protocol but at more than one site and therefore, carried out by more than one investigator.
Placebo = an inactive pill, liquid, or powder that has no treatment value.
Last database change: 10. August 2020 at 05:10